Ambea as an investment
- Growing need
- Strong market position with a Nordic platform
- High quality and competence
- Substantial growth
- Balanced risk
- Strong cash flow and stable dividend
The share
Key figures FY 2024
14,195 MSEK
Net sales
1,372 MSEK
EBITA
7%
Growth
9.7%
EBITA margin
News and press releases
Calendar
- Nov 52025-11-05 06:002025-10-06 – 2025-11-05 Silent period
- Nov 52025-11-05 07:00Interim Report Third Quarter 2025
- Nov 52025-11-05 10:00Presentation of the third quarter of 2025
- Nov 52025-11-05 12:00Group presentation for investors in Stockholm – Handelsbanken
Reports
Interim report January–June 2025
We reported a strong trend during the quarter, with clear growth in sales and earnings. We opened new units and also signed agreements for upcoming operations.
Annual report: Future-proof care
Annual report with quality & sustainability report 2024
CEO Mark Jensen about the Interim report January-June 2025
CEO Mark Jensen presents the report from Nytida Lojovägen in Lidingö.
IR Contact
Susanne Vogt
Head of IR, Reporting & Group Business Control
No matching results.
